C10H12ClN5O3
285.69 g/mol
APIDanger
Cladribine
CAS4291-63-8
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Cladribine is a purine nucleoside analogue used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It is investigated primarily for its role in the production of medications for certain hematological conditions.
pharmaceutical raw material for antineoplastic drug productscompound used in the manufacturing of treatments for hairy cell leukemia
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 4291-63-8
Related Compounds
Safety Reference
Danger
H301Toxic if swallowed
H311Toxic in contact with skin
H331Toxic if inhaled
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
InChIKey
PTOAARAWEBMLNO-KVQBGUIXSA-N
SMILES
C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
Synonyms (43)
- Cladribine (JAN/USP/INN)
- Cladribine for peak identification, European Pharmacopoeia (EP)
- Cladribine, European Pharmacopoeia (EP)
- Cladribine, United States Pharmacopeia (USP)
- 2'-Deoxy-2-chloroadenosine
- 2-CdA
- 2-Chloro-2'-deoxy-D-adenosine
- 2-Chloro-2'-deoxyadenosine
- 2-Chlorodeoxyadenosine
- 2ClAdo
- ADENOSINE, 2-CHLORO-2'-DEOXY-
- CLADRIBINE [MART.]
- Chlorodeoxyadenosine
- Cladarabine
- Cladaribine
- Cladribine
- Cladribine (Standard)
- Cladribine - Bio-X trade mark
- Cladribine CRS
- CldAdo
- Leustat
- Leustatin
- Leustatin (TN)
- Leustatine
- Litak
- Mavenclad (TN)
- Movectro
- Mylinax
- cladribina
- cladribinum
- mavenclad